Bone fracture in fragile elders

The VPHOP project produced a battery of radically innovative technologies to better predict the risk of bone fracture in osteoporosis patients. The VPH technologies were tested on four clinical cohorts: a retrospective cohort of 100 women, 50 who had a femoral neck fragility fracture, pair-matched by age, weight, height (Sheffield); a retrospective cohort of 71 women, 26 with femoral fracture, grow-matched by age, height, and weight (Reykjavik); a prospective cohort of 55 women with 22 femoral fractures (Reykjavik); and a 43 women with 19 non femoral fractures (Lyon).

The predictive accuracy of the patient-specific models based on the VPHOP technology showed improvements between 10% and 25% over the current standard of care predictors. If a patient at risk of fragility fractures is recognised and properly treated, she/he has 40-50% chances less to face an osteoporotic fracture. The improvement in predictive accuracy would avoid between 2% and 5% of the yearly incidence of OP fractures, depending on the referral criteria. OP fractures cost every year €37bn to Europe.

Most pessimistic figures would produce a cost reduction of €300m to €600m per year, for the 11400 femoral and vertebral fractures that the full-scale adoption of VPHOP technologies would involve.

Viceconti, M., Taddei, F., Cristofolini, L., Martelli, S., Falcinelli, C., Schileo, E., 2012. Are spontaneous fractures possible? An example of clinical application for personalised, multiscale neuro-musculo-skeletal modelling. J Biomech 45(3), 421-426. DOI:10.1016/j.jbiomech.2011.11.048
Falcinelli, C, Schileo E, Balistreri L, Baruffaldi F, Bordini B, Viceconti M, Albisinni U, Ceccarelli F, Milandri L, toni A, Taddei F, 2014. Multiple Loading Conditions Analysis can Improve the Association between Finite Element Bone Strength Estimates and Proximal Femur Fractures: a Preliminary Study in Elderly Women.  Bone, in press.
Public dissemination: TEDxSheffield 2012 - www.youtube.com/watch;

Avicenna Alliance news

Our new position paper on in silico evidence in the regulatory approval of medical devices is out!

The Avicenna Alliance is proud to announce the recent publication of its new position paper...

find out more ›

Happy 5th Anniversary to the Avicenna Alliance!  

5 years ago, based on the very enlightening Avicenna Roadmap Project Report, the Avicenna Alliance was established at the suggestion of European...

find out more ›

EU New Medical Device Regulation now in force! In silico mentioned for the first time

After a one-year postponement following the COVID-19 pandemic, the European Commission’s Medical Devices...

find out more ›

The European Commission adopts Communication on Europe's global approach to cooperation in research and innovation

On 18 May, the European Commission adopted a Communication on its global approach...

find out more ›

Avicenna Alliance provides feedback on the European Commissions’ roadmap for the revision of the EU general pharmaceuticals legislation

On 27 April, the Avicenna Alliance has submitted its feedback...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up